Novo Nordisk Uses AI to Make New Medicine Faster
The drug company will work with OpenAI to help research and production.
Novo Nordisk is starting a new partnership with OpenAI.
The company says artificial intelligence can help it work faster when it looks for new medicines. It also wants to use AI in factories and other parts of the business.
Novo Nordisk is known for drugs such as Wegovy and Ozempic. The company says better data tools may help it find useful ideas sooner and deliver treatments more quickly.
Many drug companies are trying AI now, but experts say the hardest scientific work still needs careful human testing and review.